(MENAFN) Egypt's Ibn Sina Pharmaceutical Industry, one of the largest drug distributors in the country is offering nearly 40 percent of its shares on the bourse in December in which might worth as much as USD90.65 million.
The Egyptian Financial Supervisory Authority (EFSA) has approved the company's prospectus with a maximum price cap of 6.66 pounds, according to an official at sole underwriter Beltone Financial Holding of the shares on Thursday.
However, head of investment banking at Beltone, Mohamed el-Akhdar said that the offering would range from 5.21 pounds to 5.95 pounds per share.
MENAFN0412201700450000ID1096183067
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.